RegentAtlantic Capital’s Eastman Chemical EMN Stock Holding History

RegentAtlantic Capital’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$738K	Sell	10,392 -772	-7%	-$69.4K	0.02%	363
2022 Q2	$1M	Sell	11,164 -454	-4%	-$47K	0.03%	320
2022 Q1	$1.3M	Sell	11,618 -334	-3%	-$39.1K	0.04%	277
2021 Q4	$1.45M	Sell	11,952 -393	-3%	-$43.7K	0.04%	259
2021 Q3	$1.24M	Sell	12,345 -274	-2%	-$30.2K	0.04%	272
2021 Q2	$1.47M	Sell	12,619 -682	-5%	-$81.9K	0.05%	242
2021 Q1	$1.47M	Buy	13,301 +81	+0.6%	+$8.79K	0.05%	228
2020 Q4	$1.33M	Buy	13,220 +1,387	+12%	+$129K	0.05%	214
2020 Q3	$924K	Buy	11,833 +3,359	+40%	+$253K	0.04%	241
2020 Q2	$590K	Buy	8,474 +2,294	+37%	+$145K	0.03%	279
2020 Q1	$288K	Sell	6,180 -280	-4%	-$18K	0.02%	338
2019 Q4	$512K	Sell	6,460 -1,531	-19%	-$118K	0.03%	305
2019 Q3	$590K	Sell	7,991 -1,010	-11%	-$72.5K	0.04%	282
2019 Q2	$701K	Sell	9,001 -1,332	-13%	-$101K	0.05%	260
2019 Q1	$784K	Buy	10,333 +1,043	+11%	+$82.9K	0.05%	245
2018 Q4	$679K	Sell	9,290 -1,828	-16%	-$146K	0.06%	246
2018 Q3	$1.06M	Buy	11,118 +68	+0.6%	+$6.74K	0.08%	221
2018 Q2	$1.1M	Buy	11,050 +357	+3%	+$37.7K	0.1%	207
2018 Q1	$1.13M	Buy	10,693 +375	+4%	+$37.9K	0.09%	204
2017 Q4	$956K	Buy	10,318 +1,185	+13%	+$108K	0.08%	217
2017 Q3	$826K	Buy	9,133 +1,895	+26%	+$161K	0.07%	228
2017 Q2	$608K	Buy	7,238 +545	+8%	+$43.9K	0.06%	250
2017 Q1	$541K	Buy	6,693 +580	+9%	+$45.6K	0.05%	266
2016 Q4	$460K	Buy	6,113 +580	+10%	+$41.9K	0.04%	277
2016 Q3	$374K	Buy	5,533 +324	+6%	+$21.7K	0.04%	295
2016 Q2	$354K	Buy	5,209 +395	+8%	+$29K	0.03%	303
2016 Q1	$348K	Buy	4,814 +195	+4%	+$12.8K	0.04%	294
2015 Q4	$312K	Sell	4,619 -7	-0.2%	-$490	0.03%	308
2015 Q3	$299K	Hold	4,626	–	–	0.03%	314
2015 Q2	$378K	Sell	4,626 -30	-0.6%	-$2.31K	0.03%	285
2015 Q1	$322K	Hold	4,656	–	–	0.03%	296
2014 Q4	$353K	Sell	4,656 -256	-5%	-$20.2K	0.03%	290
2014 Q3	$397K	Sell	4,912 -23	-0.5%	-$1.92K	0.04%	275
2014 Q2	$431K	Sell	4,935 -137	-3%	-$11.9K	0.04%	263
2014 Q1	$437K	Sell	5,072 -74	-1%	-$6.07K	0.04%	259
2013 Q4	$415K	Sell	5,146 -929	-15%	-$72.1K	0.04%	264
2013 Q3	$473K	Buy	6,075 +804	+15%	+$61.9K	0.05%	239
2013 Q2	$369K	Buy	+5,271	New	+$367K	0.04%	255

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RegentAtlantic Capital's EMN Position: Q3 2022 in Review

RegentAtlantic Capital reduced its Eastman Chemical (EMN) stake by 6.9% in Q3 2022, selling an estimated $69.4K and leaving 10,392 shares worth $738K. The position accounts for 0.02% of the portfolio, ranked #363.

RegentAtlantic Capital first reported a position in EMN in Q2 2013 and has held it in 38 quarters since. The position peaked at $1.47M in Q2 2021. 656 funds tracked by Wall St. Rank hold EMN as of Q3 2022.

RegentAtlantic Capital held 10,392 shares of Eastman Chemical worth $738K as of Q3 2022.
RegentAtlantic Capital sold 772 Eastman Chemical shares in Q3 2022, an estimated $69.4K.
Eastman Chemical made up 0.02% of RegentAtlantic Capital's portfolio in Q3 2022, its #363 holding.
RegentAtlantic Capital first reported a position in Eastman Chemical in Q2 2013 and has held it in 38 quarters since.
RegentAtlantic Capital's Eastman Chemical position peaked at $1.47M in Q2 2021.
656 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.